TWST Stock Analysis Today
Updated Nov 6, 2026 · trends, key levels, insider activity and news
Is TWST bullish or bearish today?
Daily trend: Downtrend (confirmed) — turns up above $178.53
SEPT signal: Accumulation · Consolidating
Research grade: B · fair value $84.33 (+24.4%)
TWST trend by timeframe
| Daily | Downtrend (confirmed) |
|---|---|
| 4 hour | Expanding |
| 1 hour | Leaning Bullish |
| 15 min | Strong Bullish |
| 5 min | Consolidating |
Trends are calculated from price structure and update during market hours.
TWST support and resistance levels
Resistance (above)
$128.296 touches
$153.804 touches
$178.533 touches
Support (below)
$105.471 touches
$82.807 touches
$66.439 touches
Upside zones: $156.59 / $158.58 / $160.58
See all levels on the live chart →Insider and institutional activity
Insiders
Sell30-day buys / sells
0 / 7630-day net
-$302KHedge fund holders
290Latest TWST news and filings
- NewsFiscal.ai
Twist Bioscience criticized in reports by two research outlets
Two research outlets, Hunterbrook and The Bear Cave, released critical reports about Twist Bioscience. The headline does not describe the claims or any reply from the company.
- AnalystBenzinga
Twist Bioscience shares fall after Bear Cave flags valuation concerns
Twist Bioscience shares dropped after Bear Cave raised concerns about the company's valuation. The report questions whether the stock's price is justified.
- NewsBenzinga
Short Seller Publishes Critical Piece on Twist Bioscience
A publication called The Bear Cave released a negative write-up about Twist Bioscience. The headline does not say what the piece claims.
- LegalFiscal.ai
Twist Bioscience faces proposed derivative settlement
A proposed settlement has been noticed in a derivative matter involving Twist Bioscience Corporation. The notice concerns the terms of resolving that case.
- LegalBenzinga
Twist Bioscience Offers $1M Legal Fee Deal to End Derivative Suit
The company put forward a plan to resolve a shareholder derivative case, paying $1M in legal fees and adopting changes to how it is governed. The matter would close if the proposal is accepted.
- NewsFiscal.ai
Twist Bioscience shares worth $7.3 million sold by Ark
A fund run by Ark unloaded $7.3 million of Twist Bioscience stock. The move trims the firm's holding in the DNA synthesis business.
- ProductFiscal.ai
Twist Bioscience releases Express Screening Antibodies product
The company rolled out a new antibody tool it calls Express Screening Antibodies. This adds another item to its existing catalog of offerings.
- ProductFiscal.ai
Twist Bioscience debuts MRD Express assay for cancer studies
The company released a new research tool named MRD Express, aimed at cancer studies. It is a product offering for laboratories working in oncology research.
- ProductBenzinga
Twist Bioscience debuts new antibody reagent line aimed at scaled output and assays
Twist Bioscience rolled out a new antibody product family designed for large-scale manufacturing and testing workflows. The launch adds to the company's existing antibody offerings.
Live TWST chart with trend icons on every timeframe, key levels, dark pool and options flow, news alerts, and Ask GOAX for a full analysis on demand.
Start free 7-day trialFrequently asked questions
Is TWST bullish or bearish today?
TWST daily trend: Downtrend (confirmed) — turns up above $178.53. SEPT signal: Accumulation (Consolidating). Updated Nov 6, 2026.
What is TWST's trend on each timeframe?
Daily: Downtrend (confirmed); 4 hour: Expanding; 1 hour: Leaning Bullish; 15 min: Strong Bullish; 5 min: Consolidating.
What are TWST support and resistance levels?
Support: $105.47, $82.80, $66.43. Resistance: $128.29, $153.80, $178.53. Last price $120.61.
Are insiders buying or selling TWST?
Insider signal: Sell. Last 30 days: 0 buys, 76 sells, net -$302K. 290 hedge funds hold TWST.
What is the latest news on TWST?
Nov 5, 2026: Twist Bioscience criticized in reports by two research outlets · Nov 5, 2026: Twist Bioscience shares fall after Bear Cave flags valuation concerns · Nov 5, 2026: Short Seller Publishes Critical Piece on Twist Bioscience